Los Angeles Capital Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $366K | Buy |
+11,972
| New | +$366K | ﹤0.01% | 983 |
|
|
2023
Q4 | – | Sell |
-26,651
| Closed | -$1.56M | – | 1242 |
|
|
2023
Q3 | $1.56M | Sell |
26,651
-11,701
| -31% | -$686K | 0.01% | 510 |
|
|
2023
Q2 | $2.42M | Buy |
38,352
+32,859
| +598% | +$2.07M | 0.01% | 447 |
|
|
2023
Q1 | $346K | Sell |
5,493
-600
| -10% | -$37.7K | ﹤0.01% | 966 |
|
|
2022
Q4 | $324K | Sell |
6,093
-313
| -5% | -$16.7K | ﹤0.01% | 1015 |
|
|
2022
Q3 | $359K | Sell |
6,406
-2,085
| -25% | -$117K | ﹤0.01% | 1025 |
|
|
2022
Q2 | $614K | Sell |
8,491
-914
| -10% | -$66.1K | ﹤0.01% | 890 |
|
|
2022
Q1 | $747K | Sell |
9,405
-118
| -1% | -$9.37K | ﹤0.01% | 878 |
|
|
2021
Q4 | $964K | Sell |
9,523
-14,321
| -60% | -$1.45M | ﹤0.01% | 736 |
|
|
2021
Q3 | $2.2M | Sell |
23,844
-1,280
| -5% | -$118K | 0.01% | 510 |
|
|
2021
Q2 | $2.57M | Sell |
25,124
-15,260
| -38% | -$1.56M | 0.01% | 533 |
|
|
2021
Q1 | $3.94M | Sell |
40,384
-4,348
| -10% | -$424K | 0.02% | 457 |
|
|
2020
Q4 | $3.45M | Sell |
44,732
-291
| -0.6% | -$22.4K | 0.01% | 489 |
|
|
2020
Q3 | $3.32M | Buy |
45,023
+2,645
| +6% | +$195K | 0.02% | 424 |
|
|
2020
Q2 | $3.11M | Buy |
42,378
+34,090
| +411% | +$2.5M | 0.02% | 503 |
|
|
2020
Q1 | $479K | Buy |
+8,288
| New | +$479K | ﹤0.01% | 920 |
|
|
2019
Q3 | – | Sell |
-7,816
| Closed | -$621K | – | 1372 |
|
|
2019
Q2 | $621K | Sell |
7,816
-1,770
| -18% | -$141K | ﹤0.01% | 981 |
|
|
2019
Q1 | $804K | Sell |
9,586
-9,690
| -50% | -$813K | ﹤0.01% | 932 |
|
|
2018
Q4 | $2.27M | Buy |
19,276
+6,512
| +51% | +$767K | 0.01% | 522 |
|
|
2018
Q3 | $1.54M | Buy |
+12,764
| New | +$1.54M | 0.01% | 738 |
|